Get started
INVITE-ONLY SCRIPT

FTA 2.3

By Damasta
Updated
This is the latest Version of FTA 2. It gets a separate script space to not disturb the 2.2 Users with the changes:
  • Revamped sells into one system again. It uses MFI and RSI from different periods to find better selling points. This has been a partial weakness of FTA 2.2 especially in downtrend.
  • Included Trailing-Stop with a third alert for people who like it
  • Included Take-Profit: Sell your given percentage above the last buy if you like (Not recommended with low percentages in crypto market*)
  • Finally added "sell" label above sell symbols


*Advanced Users may find Trailing-Stop in combination with a low-margin Take-Profit useful though. It can recreate Risk/Reward trading
Release Notes
fixed typo
Release Notes
Added Hourly MA available in options as additional sell restriction with variable length
Release Notes
Update 2.3.1: Squeeze out the last %!

Integrated revamped Trailing-Stop into sells:
Trailing-Stop now starts at a sell signal by default
so you sell at much higher value in most cases
About half of the sells are now 1-10% higher. You can deactivate this setting in the input settings
Release Notes
removed strategy from chart to avoid confusion
Release Notes
1H MA working again
algorithmFINNfinnsFTAMoving AveragesOscillatorstradingTrend AnalysisVolatilityVolume

Invite-only script

Access to this script is restricted to users authorized by the author and usually requires payment. You can add it to your favorites, but you will only be able to use it after requesting permission and obtaining it from its author. Contact Damasta for more information, or follow the author's instructions below.

TradingView does not suggest paying for a script and using it unless you 100% trust its author and understand how the script works. In many cases, you can find a good open-source alternative for free in our Community Scripts.

Author's instructions

″

Want to use this script on a chart?

Warning: please read before requesting access.
Damasta

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.